InvestSMART

Imagion Biosystems Limited (ASX: IBX) - Announcements

- Current share price for IBX : $0.013

ASX company news and announcements for Imagion Biosystems Limited (IBX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imagion Biosystems Limited (IBX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imagion Biosystems Limited (IBX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imagion Biosystems Limited (IBX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$7 Proposed issue of securities - IBX 28 Jul 2026 3:59PM $0.012 $0.013 risen by 8.33%
$7 Non-Dilutive Short-Term Funding Secured 28 Jul 2026 3:58PM $0.012 $0.013 risen by 8.33%
$7 Notice of General Meeting/Proxy Form 8 Jul 2026 9:32AM $0.013 $0.013 risen by 4%
$7 Imagion Extends Collaboration with Siemens Healthineers 7 Jul 2026 9:39AM $0.013 $0.013 fallen by 0%
$7 Cleansing Notice 2 Jul 2026 9:33AM $0.013 $0.013 fallen by 0%
$7 Application for quotation of securities - IBX 2 Jul 2026 9:26AM $0.013 $0.013 fallen by 0%
$7 Change of Director's Interest Notices - RP, BM, NW 1 Jul 2026 11:22AM $0.012 $0.013 risen by 8.33%
$7 Notification regarding unquoted securities - IBX 25 Jun 2026 2:47PM $0.012 $0.013 risen by 8.33%
$7 Update - Proposed issue of securities - IBX 25 Jun 2026 2:18PM $0.012 $0.013 risen by 8.33%
$7 Proposed issue of securities - IBX 25 Jun 2026 9:29AM $0.015 $0.013 fallen by 13.33%
$7 Proposed issue of securities - IBX 25 Jun 2026 9:29AM $0.015 $0.013 fallen by 13.33%
$7 Proposed issue of securities - IBX 25 Jun 2026 9:29AM $0.015 $0.013 fallen by 13.33%
$7 IBX Secures Firm Commitments for $3.75m for Clinical Trial 25 Jun 2026 9:28AM $0.015 $0.013 fallen by 13.33%
$7 Trading Halt 23 Jun 2026 9:33AM $0.015 $0.013 fallen by 13.33%
$7 Notification of cessation of securities - IBX 12 Jun 2026 3:31PM $0.016 $0.013 fallen by 18.75%
$7 Imagion Biosystems Receives IND Clearance from US FDA 2 Jun 2026 9:05AM $0.017 $0.013 fallen by 23.53%
$7 Notification of cessation of securities - IBX 28 May 2026 3:00PM $0.015 $0.013 fallen by 13.33%
$7 Results of Annual General Meeting 26 May 2026 3:21PM $0.013 $0.013 fallen by 0%
$7 Investor Presentation 26 May 2026 9:45AM $0.013 $0.013 fallen by 0%
$7 IBX Chairman's AGM Address 26 May 2026 9:42AM $0.013 $0.013 fallen by 0%
$7 Change of Director's Interest Notice - Robert Proulx 8 May 2026 12:06PM $0.016 $0.013 fallen by 18.75%
$7 Notification of cessation of securities - IBX 4 May 2026 12:11PM $0.016 $0.013 fallen by 18.75%
$7 Notice of Annual General Meeting/Proxy Form 24 Apr 2026 11:16AM $0.019 $0.013 fallen by 31.58%
$7 Notification regarding unquoted securities - IBX 23 Apr 2026 2:39PM $0.021 $0.013 fallen by 36.59%
$7 Cleansing Statement - Section 708A(12C)(e) 23 Apr 2026 2:14PM $0.021 $0.013 fallen by 36.59%

1 - 25 of 676 results

Page 1 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.